Oct 27, 20221 minANNOUNCEMENTSJoining forces with Dana-Farber Cancer Institute to investigate the role of microbiome
Oct 21, 20213 minCANCER RESEARCHToripalimab joins the list of ICIs that improve efficacy when added to chemotherapy in 1L NSCLC
Sep 30, 20214 minCANCER RESEARCHPembrolizumab may be the new standard of care for RCC with intermediate to high risk of recurrence
Sep 10, 20213 minCANCER RESEARCHIpilimumab-nivolumab combo as 2L does not improve survival for immunotherapy naive NSCLC
Sep 2, 20213 minANNOUNCEMENTSCOPERNICO Results at ERS: immunotherapy combo reduces hospitalization for COVID-19 pneumonia